Skip to navigation menu Skip to content
Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Current Research Studies

A Phase II Randomized Controlled Trial Comparing GVHD-Reduction Strategies for Allogeneic Peripheral Blood Transplantation (PBSCT) for Patients with Acute Leukemia or Myelodysplastic Syndrome: Selective Depletion of CD45RA+ Naïve T Cells (TND) vs. Post-Transplantation Cyclophosphamide (PTCy)

9749 GVHD Reduction Strategies

What is the goal of the study?

This Phase II prospective trial will compare PBSCT with (Arm A) TND, tacrolimus and methotrexate to (Arm C) PTCy for the treatment of patients with high-risk acute leukemia or MDS who require HCT for consolidation of remission.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: